OraSure Technologies | OSUR - Les Charges D'Exploitation

Prix De L'Action
3.08
Variation Quotidienne
0.12 4.05%
Mensuellement
-1.60%
Annuel
2.67%
Q2 Prévisions
2.88




Les Charges D'Exploitation Changement Date
Agilent USD 1.44B 27M 2025-12
AngioDynamics USD 81.95M 1.68M 2025-09
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Bio Techne USD 241.42M 2.52M 2025-12
Bio-Rad Laboratories USD 6.74B 6.16B 2025-09
Bruker USD 900.9M 124.3M 2025-12
Cerus USD 34.78M 2.98M 2024-12
Charles River Laboratories USD 918.41M 2.49B 2025-12
Danaher USD 5.34B 45.74B 2025-12
Dentsply International USD 423M 1.06B 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Hologic USD 349.4M 447.1M 2025-12
Illumina USD 903M 69M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
IQVIA Holdings USD 1.69B 4.47B 2025-12
Mesa Laboratories USD 33.98M 2.03M 2024-12
Mettler Toledo International USD 777.8M 42.3M 2025-12
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Quidel USD 760.9M 1.28B 2025-12
Repligen USD 177.94M 1.82M 2025-12
Revvity USD 626.22M 25.62M 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
Trinity Biotech USD 14.82M 7.81M 2025-09
Waters USD 661.85M 1.67B 2025-12